Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3085270
Max Phase: Preclinical
Molecular Formula: C30H34O12
Molecular Weight: 586.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3085270
Max Phase: Preclinical
Molecular Formula: C30H34O12
Molecular Weight: 586.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1C
Standard InChI: InChI=1S/C30H34O12/c1-12-18(34-3)5-14(6-19(12)35-4)23-15-7-20-21(39-11-38-20)8-16(15)27(17-9-37-29(33)24(17)23)42-30-26(32)25(31)28-22(41-30)10-36-13(2)40-28/h5-8,13,17,22-28,30-32H,9-11H2,1-4H3/t13-,17+,22-,23-,24+,25-,26-,27-,28-,30+/m1/s1
Standard InChI Key: UJYQSRVPFQQYFI-CBEKOONPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 586.59 | Molecular Weight (Monoisotopic): 586.2050 | AlogP: 1.94 | #Rotatable Bonds: 5 |
Polar Surface Area: 140.60 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.28 | CX Basic pKa: | CX LogP: 1.98 | CX LogD: 1.98 |
Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.49 | Np Likeness Score: 1.78 |
1. Saulnier MG, LeBoulleuc KL, Long BH, Vyas DM, Crosswell AR, Doyle TW. (1992) Synthesis of biological evaluation of 4-deshydroxy-4-methyl etoposide and teniposide analogs, 2 (10): [10.1016/S0960-894X(00)80216-4] |
Source(1):